Due to its higher genetic instability, an enhanced mutational load, and the appearance of neoantigens PD-L1 expression is more frequently found in HER2-positive and triple negative BCs than in other BC sub-entities (e.g., the luminal cohorts) [7]. This evidence concerns the gene CD274 and breast cancer.